1 2 3 4 5 6 7

читать далее ... 0 Connor BJ Inman MD et al A long-term study of the ant/inflammatory effect of low-dose budesonide plus formoterol versus high-slose budesonide in asthma Am J Respir Cnt Care Med 2000 Mar 161 (3 Pt 1) 996-1001 • 21 Juniper EF Svensson К OByrne PM et al Asthma, quality of life during 1 year of treatment with budesonide with or without formoterol // Eur Respir J 1999 Nov 14 (5)1038-43 22 Nightingale JA Rogers DF, Barnes PJ Comparison of the effects of salmeterol and formoferol in patients with severe asthma // Chest 2002 May 121 (5) 1401-6 23 Condemi JJ Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease a multicenter, randomized, open-label trial//CIm Ther 2001 Sep 23 (9) 1529-41 24 Brambilla С Le Bros V Bourdeix I Efficacy of Foradil in Asthma (EFORA) French Study Group Formoterol 12 microg BID administered via single-dose dry powder inhaler in adults with asthma suboptimally controlled with salmeterol or on-demand salbutamol a multicenter randomized open-label parallel-group study//Clin Ther 2003 Jul 25 (7) 2022-36 25 Mitchell С Jenkms С Scicchitano R et al Formoterol (Foradil) and medium-high doses of inhaled corticosteroids are more effective than high doses of corticosteroids in moderate-to-severe asthma //Pulm Pharmacol Ther 2003 16 (5) 299-306 26 Bensch G Berger WE Blokhin BM et al International Study Group on Foradil Evaluation in Pediatnc Asthma One-year efficacy and safety of inhaled tormoterol dry powder in children with persistent asthma //Ann Allergy Asthma Immunol 2002 Aug 89 (2)180-90 27 Walters EH Walters JA Gibson PW Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma // Cochrane Database Syst Rev 2002 (4) CD003901 28 Greenstone IR Hi Chroinin MN Masse V et al Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma // Cochrane Database Syst Rev 2005 Oct 19, (4) CD005533 29 Rabe KF Formoterol in clinical practice - safety issues // Respir Med 2001 Aug,95 SuppI В S21-5 30 Kruse M Rosenkranz В Dobson С et al Safety and tolerability of high-dose for moterol (Aerolizer) and salbutamol (pMDI) in patients with mild/moderate, persistent asthma//Pulm Pharmacol Ther 2005 18 (3) 229-34 31 GuhanAR CooperS OborneJetal Systemic effects of formoterol and salmeterol a dose-response comparison in healthy sublets // Thorax 2000 Aug 55 (8) 650-6 32 van Schayck CP Cloosterman SG Biil-Hofland ID et al Is the increase in bronchial responsiveness or FEV1 shortly after cessation of beta2-agonists reflecting a real deterioration of the disease in allergic asthmatic patients7 A comparison between short-acting and long-acting beta2-agonists // Respir Med 2002 Mar 96 (3) 155-62 33 Mann M Chowdhury В Sullivan E et al Serious asthma exacerbations in asthmatics treated with high-dose formoterol//Chest 20Источник: Вознесенский Н.А. Русский медицинский журнал. 2006. Т.14. №7. С.514-517